The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic

Cancer Cell

Volumn 27, Issue 6, 2015, Pages 751-753

  Politi, Katerina ^a,b   Ayeni, Deborah ^a   Lynch, Thomas ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFATINIB; CETUXIMAB; DURVALUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; INSULIN RECEPTOR; MERELETINIB; METFORMIN; ROCILETINIB; SELUMETINIB; SOMATOMEDIN C RECEPTOR; EGFR PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR;

DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; GENE MUTATION; HUMAN; HYPERGLYCEMIA; LUNG CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SHORT SURVEY; SKIN TOXICITY; ANTAGONISTS AND INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; ENZYMOLOGY; GENETICS; LUNG NEOPLASMS; METABOLISM; MUTATION; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84930582843     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.05.012     Document Type: Short Survey

References (10)

1. Cross D.A., Ashton S.E., Ghiorghiu S., Eberlein C., Nebhan C.A., Spitzler P.J., Orme J.P., Finlay M.R., Ward R.A., Mellor M.J., et al. Cancer Discov. 2014, 4:1046-1061.
2. Ercan D., Choi H.G., Yun C.H., Capelletti M., Xie T., Eck M.J., Gray N.S., Janne P.A. Clin. Cancer Res. 2015, Published online May6, 2015. 10.1158/1078-0432.CCR-14-2789.
3. Janjigian Y.Y., Smit E.F., Groen H.J., Horn L., Gettinger S., Camidge D.R., Riely G.J., Wang B., Fu Y., Chand V.K., et al. Cancer Discov. 2014, 4:1036-1045.
4. Jänne P.A., Yang J.C., Kim D.W., Planchard D., Ohe Y., Ramalingam S.S., Ahn M.J., Kim S.W., Su W.C., Horn L., et al. N.Engl. J. Med. 2015, 372:1689-1699.
5. Niederst M.J., Hu H., Mulvey H.E., Lockerman E.L., Garcia A.R., Piotrowska Z., Sequist L.V., Engelman J.A. Clin. Cancer Res. 2015, Published online May 11, 2015. 10.1158/1078-0432.CCR-15-0560.
6. Piotrowska Z., Niederst M.J., Karlovich C.A., Wakelee H.A., Neal J.W., Mino-Kenudson M., Fulton L., Hata A.N., Lockerman E.L., Kalsy A., et al. Cancer Discov. 2015, Published online May 1, 2015. 10.1158/2159-8290.CD-15-0399.
7. Sequist L.V., Soria J.C., Goldman J.W., Wakelee H.A., Gadgeel S.M., Varga A., Papadimitrakopoulou V., Solomon B.J., Oxnard G.R., Dziadziuszko R., et al. N.Engl. J. Med. 2015, 372:1700-1709.
8. Thress K.S., Paweletz C.P., Felip E., Cho B.C., Stetson D., Dougherty B., Lai Z., Markovets A., Vivancos A., Kuang Y., et al. Nat Med. 2015, Published online May 4, 2015. 10.1038/nm.3854.
9. Walter A.O., Sjin R.T., Haringsma H.J., Ohashi K., Sun J., Lee K., Dubrovskiy A., Labenski M., Zhu Z., Wang Z., et al. Cancer Discov. 2013, 3:1404-1415.
10. Wheaton W.W., Weinberg S.E., Hamanaka R.B., Soberanes S., Sullivan L.B., Anso E., Glasauer A., Dufour E., Mutlu G.M., Budigner G.S., Chandel N.S. eLife 2014, 3:e02242.